Aligner Sales Drive Q2 Beat
Align Technology Reports Strong Q2 Performance, Exceeding Estimates with Record Aligner Shipments
Anonymous
Key Points
1
Clear aligner shipments to orthodontists rose 7.8% year over year, while shipments to general-practice dentists rose 6.6%, signaling notable channel mix growth beyond overall quarterly figures.
2
Teen and growing-patient starts reached 240,000 in Q2, up 7.2% year over year, with growth led by China, Japan, Turkey, India and Brazil, supported by continued adoption of Invisalign First and related pediatric products.
3
North American results were described as stable, with growth in the dental-service-organization channel helping offset weaker retail demand; management signaled efforts to bolster North American retail performance through financing and education initiatives while not assuming macro improvements.
4
GAAP earnings per share for the quarter were $1.51 with net income of about $108.3 million, alongside revenue of $1.056 billion, providing a contrast to the non-GAAP figure highlighted in the summary.
5
There is inconsistency in reported Invisalign doctor counts across sources: one report cites 89,200 doctors submitting cases, while another cites 85,275 Invisalign Trained Doctors at quarter-end, indicating different reporting benchmarks or timeframes.
Align Technology beat Wall Street expectations in the second quarter of 2026, posting revenue of $1.06 billion — up 4.3% year over year — on record clear aligner shipments of 692,000 cases, according to Yahoo Finance. Non-GAAP earnings per share came in at $2.64, topping analyst estimates and extending a streak of quarterly outperformance.
The strong quarter was powered by an 8.2% jump in clear aligner revenue to $870.9 million, with each case averaging $1,260 in price. Growth was sharpest outside North America, with double-digit gains across Asia-Pacific, Europe, the Middle East and Africa, and Latin America, Seeking Alpha reported.
Record Aligner Shipments Fuel Global Revenue Gains
Clear aligner shipments rose 7.4% year over year to 692,000 cases in Q2. Orthodontists saw a 7.8% increase in shipments, while general-practice dentists were up 6.6%, according to Yahoo Finance. Both channels grew, signaling broad demand beyond any single provider type.
A total of 89,200 Invisalign doctors submitted cases during the quarter, a 3.4% rise, with doctor utilization — meaning how often each doctor sent in a case — up 3.8%, per Guru Focus. A separate figure cited 85,275 trained doctors at quarter-end, reflecting different ways the company tracks its provider base.
Teen and Young-Patient Starts Hit 240,000, Led by Emerging Markets
Starts among teens and younger patients reached 240,000 in Q2, up 7.2% year over year, according to Yahoo Finance. China, Japan, Turkey, India, and Brazil led that growth. Align credited its Invisalign First product line — built for younger, still-growing patients — for much of the momentum.
The teen segment has become one of Align's fastest-growing categories. Invisalign First and related pediatric products are designed for kids whose teeth are still coming in. That focus on younger patients gives Align a longer runway with each customer, since treatment often continues into adulthood.
North America Stays Stable as Macro Uncertainty Lingers
North American results were described as stable but not a standout. Growth in the dental-service-organization channel — large corporate dental groups — helped offset softer retail demand from individual offices, per Guru Focus. Management did not assume any improvement in the broader economy going forward.
To keep North American sales steady, Align said it is leaning on patient financing options and doctor education programs, according to Eritv News. The company flagged uneven macro conditions but stopped short of issuing a cautious formal guidance cut, instead reaffirming a careful outlook for the rest of the year.
Align Eyes 2027 Margin Expansion and $500M in Buybacks
Beyond the quarter, Align outlined a plan to raise its 2027 operating margin by 100 basis points — roughly one percentage point — compared to 2026 levels, Seeking Alpha reported. The company also said it plans to buy back between $400 million and $500 million of its own stock during 2026.
On a GAAP basis — which includes stock costs and other items non-GAAP strips out — earnings per share were $1.51, with net income of about $108.3 million, per Eritv News. That gap between the $2.64 non-GAAP and $1.51 GAAP figures is worth noting for investors comparing results across companies.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
15
Articles
39
Reach
54
A
AnonymousAuthor
